Health News

New research published in this month’s edition of Obstetrics & Gynecology (Vol. 113, Issue 4), by a team of investigators from The Cancer Institute of New Jersey (CINJ) shows better survival outcomes for women who have cancer of the ovaries and endometrial lining of the uterus at the same time (synchronous) than those who only have one tumor in the ovaries. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Read more

Filed under: Women's Health
Tags: cancer, Tumor, Women's Health

Related posts

• Younger Women’s Dense Breast Tissue Limits Effectiveness Of Mammograms, Study Finds (0)
  Mammography alone is not effective for breast cancer screening in women in their 40s because their breast tissue usually appears the same color as tumors in the images, according to a Stanford University study published recently in the Journal of the National Cancer Institute, Newsday/Chicago Tribune reports... Read more [tags] Women's Health [/tags]
  
  
• Women With Breast Implants Encouraged To Go Beyond Regular Mammogram Screening (0)
  NewImage.com, the premier online destination for personal image enhancement solutions, is pleased to support National Breast Cancer Awareness Month for a second year by helping raise awareness of the importance of early detection and encouraging women with breast implants to go beyond regular mammography screenings to reduce the risk of possibly missing a tumor hidden [...]
  
  
• When Might Preventive Mastectomy Be Right Choice? Study Investigates (0)
  A new US study has sought to help women who have been treated for breast cancer in one breast to make a better informed decision about whether to have a preventive mastectomy to remove the unaffected breast by identifying which types of patients and tumors present the highest risk of [...]
  
  
• Vitamin D Relieves Joint, Muscle Pain For Breast Cancer Patients (0)
  High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis. The drugs, known as aromatase inhibitors, are commonly prescribed to shrink breast tumors fueled by the hormone estrogen and help prevent cancer recurrence... Read more [tags] Women's [...]
  
  
• Swiss Breast Cancer Patient Becomes First In World To Receive Treatment Using Gated RapidArc From Varian Medical Systems (0)
  A 51-year-old breast cancer patient from Switzerland has become the first person in the world to be treated using Gated RapidArc®, which makes it possible to monitor patient breathing and compensate for tumor motion while quickly delivering radiotherapy during a continuous rotation around the patient... Read more [tags] Women's Health [/tags]